Denzibet

DENZIBET

Itraconazole

De-Mont Research Laboratories (Pvt.) Ltd.

Drug Identity

Active Ingredient
Itraconazole
Drug Class
Antimycotics Systemic Use
ATC Code
J02AC02
Status
Essential Medicine

How to Take It

Dosage information not available for this product.

Safety Alerts

Acute porphyrias, heart failure

Important Warnings

History of liver disease, liver toxicity with other drug therapy, caution is advised to patients at high risk of heart failure
patients receiving high doses and longer treatment courses, older adults and those with cardiac disease, patients with chronic lung disease (including chronic obstructive pulmonary disease) associated with pulmonary hypertension, patients receiving treatment with negative in otropic drugs, e
calcium channel blockers
Itraconazole should be avoided in patients with ventricular dysfunction or a history of heart failure unless the infection is serious
Contraception must be used during and 1 month after treatment

Side Effects

Abdominal paindiarrhoeadyspneaheadachehepatitishypokalaemianausearashtaste disturbancesvomitingdizzinessdyspepsiaflatulencemenstrual disordermyalgia

Drug Interactions

Rifampicin
cyclosporin
H2 antagonists
antacids.

Pregnancy & Lactation

Pregnancy
Caution advised
Lactation
Not recommended.

Price Intelligence

Rs 588.87
DRAP approved maximum price · per pack of 4 · approved 01 Jul, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 4Rs 588.87

Should you consider an alternative?

Other options containing Itraconazole, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.